vs
Side-by-side financial comparison of Heritage Insurance Holdings, Inc. (HRTG) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $215.3M, roughly 1.4× Heritage Insurance Holdings, Inc.). Heritage Insurance Holdings, Inc. runs the higher net margin — 31.0% vs 12.8%, a 18.1% gap on every dollar of revenue. On growth, Heritage Insurance Holdings, Inc. posted the faster year-over-year revenue change (2.4% vs -6.4%). Over the past eight quarters, Heritage Insurance Holdings, Inc.'s revenue compounded faster (6.1% CAGR vs 4.2%).
United Property & Casualty Insurance Company, Inc. is an American property and casualty insurance company with headquarters in Florida. It writes commercial, residential, homeowners’, and flood insurance policies in several coastal states.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
HRTG vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $215.3M | $295.9M |
| Net Profit | $66.7M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 41.6% | 18.4% |
| Net Margin | 31.0% | 12.8% |
| Revenue YoY | 2.4% | -6.4% |
| Net Profit YoY | 228.6% | 68.3% |
| EPS (diluted) | $2.15 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $215.3M | $295.9M | ||
| Q3 25 | $212.5M | — | ||
| Q2 25 | $208.0M | $317.0M | ||
| Q1 25 | $211.5M | $316.2M | ||
| Q4 24 | $210.3M | $297.0M | ||
| Q3 24 | $211.8M | $289.5M | ||
| Q2 24 | $203.6M | $306.1M | ||
| Q1 24 | $191.3M | $303.4M |
| Q4 25 | $66.7M | $38.0M | ||
| Q3 25 | $50.4M | — | ||
| Q2 25 | $48.0M | $-17.7M | ||
| Q1 25 | $30.5M | $22.6M | ||
| Q4 24 | $20.3M | $34.9M | ||
| Q3 24 | $8.2M | $33.6M | ||
| Q2 24 | $18.9M | $40.6M | ||
| Q1 24 | $14.2M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 41.6% | 18.4% | ||
| Q3 25 | 33.0% | — | ||
| Q2 25 | 31.2% | -7.5% | ||
| Q1 25 | 20.1% | 12.2% | ||
| Q4 24 | 15.0% | 16.0% | ||
| Q3 24 | 5.5% | 13.8% | ||
| Q2 24 | 13.6% | 15.0% | ||
| Q1 24 | 11.9% | 22.1% |
| Q4 25 | 31.0% | 12.8% | ||
| Q3 25 | 23.7% | — | ||
| Q2 25 | 23.1% | -5.6% | ||
| Q1 25 | 14.4% | 7.1% | ||
| Q4 24 | 9.7% | 11.7% | ||
| Q3 24 | 3.8% | 11.6% | ||
| Q2 24 | 9.3% | 13.3% | ||
| Q1 24 | 7.4% | 16.2% |
| Q4 25 | $2.15 | $0.24 | ||
| Q3 25 | $1.63 | — | ||
| Q2 25 | $1.55 | $-0.11 | ||
| Q1 25 | $0.99 | $0.14 | ||
| Q4 24 | $0.66 | $0.22 | ||
| Q3 24 | $0.27 | $0.21 | ||
| Q2 24 | $0.61 | $0.26 | ||
| Q1 24 | $0.47 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $559.3M | $172.9M |
| Total DebtLower is stronger | $78.4M | $260.0M |
| Stockholders' EquityBook value | $505.3M | $2.0B |
| Total Assets | $2.2B | $2.5B |
| Debt / EquityLower = less leverage | 0.16× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $559.3M | $172.9M | ||
| Q3 25 | $560.4M | — | ||
| Q2 25 | $473.5M | $162.2M | ||
| Q1 25 | $425.9M | $140.7M | ||
| Q4 24 | $452.7M | $177.5M | ||
| Q3 24 | $509.9M | $187.5M | ||
| Q2 24 | $480.9M | $152.9M | ||
| Q1 24 | $386.1M | $145.3M |
| Q4 25 | $78.4M | $260.0M | ||
| Q3 25 | $79.3M | — | ||
| Q2 25 | $92.4M | $346.0M | ||
| Q1 25 | $94.8M | $330.0M | ||
| Q4 24 | $116.3M | $300.0M | ||
| Q3 24 | $118.6M | $300.0M | ||
| Q2 24 | $120.8M | $319.0M | ||
| Q1 24 | $123.0M | $389.0M |
| Q4 25 | $505.3M | $2.0B | ||
| Q3 25 | $437.3M | — | ||
| Q2 25 | $383.3M | $1.9B | ||
| Q1 25 | $329.0M | $2.0B | ||
| Q4 24 | $290.8M | $2.1B | ||
| Q3 24 | $279.3M | $2.1B | ||
| Q2 24 | $255.3M | $2.1B | ||
| Q1 24 | $234.9M | $2.0B |
| Q4 25 | $2.2B | $2.5B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $2.2B | $2.6B | ||
| Q4 24 | $2.5B | $2.7B | ||
| Q3 24 | $2.4B | $2.7B | ||
| Q2 24 | $2.6B | $2.7B | ||
| Q1 24 | $2.1B | $2.7B |
| Q4 25 | 0.16× | 0.13× | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.24× | 0.18× | ||
| Q1 25 | 0.29× | 0.16× | ||
| Q4 24 | 0.40× | 0.14× | ||
| Q3 24 | 0.42× | 0.14× | ||
| Q2 24 | 0.47× | 0.15× | ||
| Q1 24 | 0.52× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $182.2M | — |
| Free Cash FlowOCF − Capex | $174.2M | — |
| FCF MarginFCF / Revenue | 80.9% | — |
| Capex IntensityCapex / Revenue | 3.7% | — |
| Cash ConversionOCF / Net Profit | 2.73× | — |
| TTM Free Cash FlowTrailing 4 quarters | $337.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $182.2M | — | ||
| Q3 25 | $124.3M | — | ||
| Q2 25 | $43.3M | $98.2M | ||
| Q1 25 | $837.0K | $41.1M | ||
| Q4 24 | $87.1M | $84.3M | ||
| Q3 24 | $-13.4M | $63.9M | ||
| Q2 24 | $152.2M | $75.5M | ||
| Q1 24 | $4.3M | $81.0M |
| Q4 25 | $174.2M | — | ||
| Q3 25 | $122.7M | — | ||
| Q2 25 | $41.8M | $93.3M | ||
| Q1 25 | $-1.3M | $31.0M | ||
| Q4 24 | $78.9M | $77.5M | ||
| Q3 24 | $-16.3M | $54.7M | ||
| Q2 24 | $149.8M | $57.5M | ||
| Q1 24 | $4.1M | $64.5M |
| Q4 25 | 80.9% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 20.1% | 29.4% | ||
| Q1 25 | -0.6% | 9.8% | ||
| Q4 24 | 37.5% | 26.1% | ||
| Q3 24 | -7.7% | 18.9% | ||
| Q2 24 | 73.6% | 18.8% | ||
| Q1 24 | 2.1% | 21.3% |
| Q4 25 | 3.7% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 1.0% | 3.2% | ||
| Q4 24 | 3.9% | 2.3% | ||
| Q3 24 | 1.4% | 3.2% | ||
| Q2 24 | 1.2% | 5.9% | ||
| Q1 24 | 0.1% | 5.4% |
| Q4 25 | 2.73× | — | ||
| Q3 25 | 2.47× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.03× | 1.82× | ||
| Q4 24 | 4.29× | 2.42× | ||
| Q3 24 | -1.64× | 1.90× | ||
| Q2 24 | 8.07× | 1.86× | ||
| Q1 24 | 0.30× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HRTG
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
